Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 3/2012

01-06-2012 | Erratum

Erratum to: Respiratory viruses in patients and employees in an intensive care unit

Authors: D. Stupica, L. Lusa, M. Petrovec, N. Žigon, M. Jevšnik, P. Bogovič, F. Strle

Published in: Infection | Issue 3/2012

Login to get access

Excerpt

Unfortunately some errors occurred in the published version. …
Metadata
Title
Erratum to: Respiratory viruses in patients and employees in an intensive care unit
Authors
D. Stupica
L. Lusa
M. Petrovec
N. Žigon
M. Jevšnik
P. Bogovič
F. Strle
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Infection / Issue 3/2012
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0252-7

Other articles of this Issue 3/2012

Infection 3/2012 Go to the issue

Clinical and Epidemiological Study

Characteristics of non-typhi Salmonella gastroenteritis associated with bacteremia in infants and young children

Clinical and Epidemiological Study

Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance

Clinical and Epidemiological Study

Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis

Review

Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example

Correspondence

Recurrent fever and bacteraemia after endoscopic variceal haemostasis with cyanoacrylate: a case report

Clinical and Epidemiological Study

Changing epidemiology of methicillin-resistant Staphylococcus aureus in the Veterans Affairs Healthcare System, 2002–2009
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits